Volver a Agenda
Session 3, Track B: Equity, Diversity, Inclusion and Accessibility (EDIA) in Trials
Session Chair(s)
Rebecca Barnes, MS
Executive Director
Network of Networks (N2), Canada
Equity, diversity, inclusion and accessibility (EDIA) in clinical trial participants is an important topic to ensure the benefits of trials are shared by everyone. Clinical trials have often lacked representation from various equity-denied groups and Canada is well positioned to conduct clinical trials in a way that addresses these historical shortfalls. In this session, speakers will describe strategies to help sites and sponsors in improving EDIA in clinical trials, including early patient and community engagement, site selection, and use of AI and technology. Two communities this session will focus on are new immigrants to Canada, and members of the sexually and gender diverse community.
Learning Objective : - Understand how to implement equity, diversity, inclusion and accessibility strategies in clinical trials, including through early planning and use of AI and technology
- Develop strategies that promote inclusion for new immigrants in clinical trials
- Explore barriers in the clinical trial landscape that lead to exclusion of sexual and gender diverse people and identify inclusive practices throughout the trial pathway from design to delivery
Speaker(s)
Strategies to Bridge the Diversity, Equity and Inclusion Gap in Clinical Trials
Sabrina Ramkellawan
AxialBridge, Canada
Chief Operating Officer
Queering Clinical Trials: Cultural Sensitivity from Bench to Bedside
Kim Meeking
Queering Cancer, Canada
Lead for Content, Community and Collaborations
Bridging the Gap: Advancing New Immigrant Participation in Clinical Trials
Munaza Jamil
McMaster University/N2 [canada], Canada
Faculty, Applied Clin Research Program
¿Tiene una cuenta?